
0:00
5:46
Biohackers have been using CGMs (Continuous Glucose Monitors) for years.
Sharam Fouladgar-Mercer is the co-founder of Signos, the first ever FDA-cleared CGM for weight management.
So how has running a company (and looking at all the data from their 35k person clinical trial) changed his own routine?
Follow Sharam Fouladgar-Mercer on LinkedIn.
Więcej odcinków z kanału "Biohacking News by Zestology"



Nie przegap odcinka z kanału “Biohacking News by Zestology”! Subskrybuj bezpłatnie w aplikacji GetPodcast.








